TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$60 Million

TransMedics Group, Inc

Sole Placement Agent and Exclusive Financial Advisor, August 2022

TransMedics Group, Inc
Sr. Secured Term Loan

TransMedics Group, Inc. (NASDAQ: TMDX) is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

More Like This

Mar 2024

Exchange of all Outstanding Series B Convertible Preferred Stock for Common Stock

Financial Advisor

View Details >
Mar 2024
$600 Million

Follow-on Offering

Bookrunner

View Details >
Mar 2024
$150 Million

Underwritten Offering

Lead Left Bookrunner

View Details >